Anticonvulsant and Neuroprotective Effects of Cannabidiol During the Juvenile Period

Journal of Neuropathology and Experimental Neurology
Linda K Friedman, Joann P Wongvravit

Abstract

Anticonvulsant effects of cannabidiol (CBD), a nonpsychoactive cannabinoid, have not been investigated in the juvenile brain. We hypothesized that CBD would attenuate epileptiform activity at an age when the brain first becomes vulnerable to neurotoxicity and social/cognitive impairments. To induce seizures, kainic acid (KA) was injected either into the hippocampus (KAih) or systemically (KAip) on postnatal (P) day 20. CBD was coadministered (KA + CBDih, KA + CBDip) or injected 30 minutes postseizure onset (KA/CBDih, KA/CBDip). Hyperactivity, clonic convulsions, and electroencephalogram rhythmic oscillations were attenuated or absent after KA + CBDih and reduced after KA + CBDip. NeuN immunohistochemistry revealed neuroprotection. Augmented reactive glia number and expression were reversed in CA1 but persisted deep within the dentate hilus. Parvalbumin-positive (PV+) interneurons were reduced in both models, whereas immunolabeling was dramatically increased within ipsilateral and contralateral dendritic/neuropilar fields following KA + CBDih. Cannabinoid receptor 1 (CB1) expression was minimally affected after KAih contrasting elevations observed after KAip. Intracranial coadministration data suggest that CBD has higher efficac...Continue Reading

References

Apr 24, 1989·Neuroscience Letters·A RepresaY Ben-Ari
Dec 15, 1987·Brain Research·E A CavalheiroL Turski
Dec 1, 1980·Journal of Neuroscience Methods·G PaxinosP C Emson
Jun 1, 1984·Brain Research·Y Ben-AriL Nitecka
Aug 1, 1995·Brain Research. Molecular Brain Research·L de LeceaE Soriano
Jul 9, 1999·Neurochemistry International·J M FritschyF Loup
May 31, 2002·Pharmacological Reviews·A C HowlettR G Pertwee
Nov 29, 2005·Seizure : the Journal of the British Epilepsy Association·H LiuJ Kaur
Jan 4, 2007·Molecular Interventions·Linda K Friedman
Jan 16, 2007·Trends in Pharmacological Sciences·Tibor HarkanyKen Mackie
Feb 23, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·MacKenzie A HowardEdwin W Rubel
Dec 11, 2007·Annals of Neurology·Henrik H HansenChrysanthy Ikonomidou
Sep 9, 2008·Nature Medicine·István Katona, Tamás F Freund
Dec 17, 2008·Journal of Bodywork and Movement Therapies·John M McPartland
Jan 8, 2009·Physiological Reviews·Masanobu KanoMasahiko Watanabe
Jul 16, 2009·Progress in Lipid Research·Mauro Maccarrone
Nov 13, 2009·The Journal of Pharmacology and Experimental Therapeutics·Nicholas A JonesGary J Stephens
Dec 17, 2009·Journal of Neurophysiology·Ping Jun Zhu, David M Lovinger
Dec 24, 2010·British Journal of Pharmacology·Luciano De PetrocellisVincenzo Di Marzo
Jul 29, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Soo Yeun LeeIvan Soltesz

❮ Previous
Next ❯

Citations

Jan 12, 2019·Neuropharmacology·Megan N HuizengaPatrick A Forcelli
Nov 8, 2019·Medical Cannabis and Cannabinoids·Ana Gabriela Hounie, Marco Agassiz Almeida Vasques

❮ Previous
Next ❯

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.